OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
12.15
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
12.33
+0.18 (1.48%)
After-hours: Mar 28, 2024, 6:45 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $220.55 million as of March 28, 2024. Its market cap has decreased by -6.47% in one year.
Market Cap
220.55M
Enterprise Value
157.16M
1-Year Change
-6.47%
Ranking
Category
Stock Price
$12.15
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $220.55M, an increase of 544.89%. That is a compound annual growth rate of 38.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 220.60M | 1.43% |
Mar 26, 2024 | 217.50M | 1.73% |
Mar 25, 2024 | 213.80M | 2.69% |
Mar 22, 2024 | 208.20M | -6.30% |
Mar 21, 2024 | 222.20M | -3.31% |
Mar 20, 2024 | 229.80M | 0.48% |
Mar 19, 2024 | 228.70M | 3.20% |
Mar 18, 2024 | 221.60M | -3.82% |
Mar 15, 2024 | 230.40M | -1.75% |
Mar 14, 2024 | 234.50M | -4.52% |
Mar 13, 2024 | 245.60M | -0.20% |
Mar 12, 2024 | 246.10M | -14.13% |
Mar 11, 2024 | 286.60M | -2.35% |
Mar 8, 2024 | 293.50M | 0.07% |
Mar 7, 2024 | 293.30M | 3.97% |
Mar 6, 2024 | 282.10M | 0.71% |
Mar 5, 2024 | 280.10M | -4.27% |
Mar 4, 2024 | 292.60M | 1.07% |
Mar 1, 2024 | 289.50M | 0.73% |
Feb 29, 2024 | 287.40M | 1.41% |
Feb 28, 2024 | 283.40M | 0.67% |
Feb 27, 2024 | 281.50M | 3.23% |
Feb 26, 2024 | 272.70M | -0.98% |
Feb 23, 2024 | 275.40M | -0.18% |
Feb 22, 2024 | 275.90M | -0.93% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Compugen | 224.67M |
Zevra Therapeutics | 224.14M |
Pyxis Oncology | 222.65M |
Vanda Pharmaceuticals | 222.09M |
Omeros | 217.51M |
908 Devices | 217.21M |
Acumen Pharmaceuticals | 217.16M |
Ovid Therapeutics | 215.67M |